NDTV Profit on MSN
Lupin's Pune Facility Gets Four Observations After US FDA Inspection
The US FDA conducted a product-specific pre-approval inspection at the company’s Pune biotech facility from Sept. 8 to Sept.
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong Pharmaceutical Co., Ltd. for the rights to develop and commercialize OCU400, Ocugen’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback